XML 380 R59.htm IDEA: XBRL DOCUMENT v3.25.0.1
REVENUE RECOGNITION - Schedule of Net Sales by Category (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disaggregation of Revenue [Line Items]      
Revenue $ 4,373.4 $ 4,655.6 $ 4,451.6
CSCA      
Disaggregation of Revenue [Line Items]      
Revenue 2,693.7 2,962.3 2,925.9
CSCA | Upper Respiratory      
Disaggregation of Revenue [Line Items]      
Revenue 500.3 561.4 567.3
CSCA | Digestive Health      
Disaggregation of Revenue [Line Items]      
Revenue 497.4 507.5 498.8
CSCA | Nutrition      
Disaggregation of Revenue [Line Items]      
Revenue 449.5 563.2 524.3
CSCA | Pain and Sleep-Aids      
Disaggregation of Revenue [Line Items]      
Revenue 345.5 397.2 412.8
CSCA | Healthy Lifestyle      
Disaggregation of Revenue [Line Items]      
Revenue 306.8 311.4 287.9
CSCA | Oral Care      
Disaggregation of Revenue [Line Items]      
Revenue 275.4 310.4 315.4
CSCA | Skin Care      
Disaggregation of Revenue [Line Items]      
Revenue 220.1 240.5 237.6
CSCA | Women's Health      
Disaggregation of Revenue [Line Items]      
Revenue 81.1 48.6 47.4
CSCA | Vitamins, Minerals, and Supplements ("VMS")      
Disaggregation of Revenue [Line Items]      
Revenue 14.5 18.5 28.3
CSCA | Other CSCA      
Disaggregation of Revenue [Line Items]      
Revenue 3.1 3.6 6.1
CSCI      
Disaggregation of Revenue [Line Items]      
Revenue 1,679.6 1,693.3 1,525.7
CSCI | Upper Respiratory      
Disaggregation of Revenue [Line Items]      
Revenue 282.1 299.1 268.7
CSCI | Digestive Health      
Disaggregation of Revenue [Line Items]      
Revenue 36.5 41.0 35.5
CSCI | Pain and Sleep-Aids      
Disaggregation of Revenue [Line Items]      
Revenue 222.2 222.9 200.2
CSCI | Healthy Lifestyle      
Disaggregation of Revenue [Line Items]      
Revenue 225.8 225.7 209.7
CSCI | Oral Care      
Disaggregation of Revenue [Line Items]      
Revenue 99.4 101.5 94.8
CSCI | Skin Care      
Disaggregation of Revenue [Line Items]      
Revenue 410.0 372.5 334.6
CSCI | Women's Health      
Disaggregation of Revenue [Line Items]      
Revenue 132.8 119.7 96.1
CSCI | Vitamins, Minerals, and Supplements ("VMS")      
Disaggregation of Revenue [Line Items]      
Revenue 173.5 185.5 183.9
CSCI | Other CSCI      
Disaggregation of Revenue [Line Items]      
Revenue $ 97.3 $ 125.4 $ 102.2